Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies

被引:162
|
作者
Arima, K
Hirai, S
Sunohara, N
Aoto, K
Izumiyama, Y
Uéda, K
Ikeda, K
Kawai, M
机构
[1] Tokyo Inst Psychiat, Dept Ultrastruct & Histochem, Setagaya Ku, Tokyo 1568585, Japan
[2] Tokyo Inst Psychiat, Dept Neurochem, Setagaya Ku, Tokyo 1568585, Japan
[3] Natl Ctr Hosp Mental Nervous & Muscular Disorders, NCNP, Dept Lab Med, Kodaira, Tokyo 1878551, Japan
[4] Natl Ctr Hosp Mental Nervous & Muscular Disorders, NCNP, Dept Neurol, Kodaira, Tokyo 1878551, Japan
[5] Natl Hakone Hosp, Dept Neurol, Odawara, Kanagawa 2500032, Japan
关键词
Lewy body; NACP; synuclein; tau; filament aggregation; neuronal degeneration;
D O I
10.1016/S0006-8993(99)01848-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The precursor of the non-A beta-component of Alzheimer's disease (AD) amyloid (NACP, alpha-synuclein) aggregates into insoluble filaments of Lewy bodies (LBs) in Parkinson's disease (PD) and dementia with LBs (DLB). The microtubule-associated protein tan is an integral component of filaments of neurofibrillary tangles (NFTs). NFTs are occasionally found in brains of PD and DLB; however, the presence of NFTs or tau-epitopes within LB-containing neurons is rare. Double-immunofluorescence study and peroxidase-immunohistochemical study in serial sections, performed to examine the co-localization of tau- and NACP-epitopes in the brainstem of PD and DLB, demonstrated that four different epitopes of tau including phosphorylation-dependent and independent ones were present in a minority of LBs, but more often than previously considered. A tau (tau2)-epitope was localized to filaments in the outer layers of brainstem-type LBs by immunoelectron microscopy. Therefore, we conclude that tau is incorporated into filaments in certain LBs, Extensive investigation has enabled us to classify this co-localization into four types: type 1, LBs with ring-shaped tau-immunoreactivity; type 2, LBs surrounded by NFTs; type 3, NACP- and tau-immunoreactive filamentous and granular masses; and type 4, NACP- and tau-immunoreactive dystrophic neurites. This study raises a new question whether aggregation and hyperphosphorlation of tau in PD and DLB are triggered by the collapse of intraneuronal organization of microtubules due to NACP-filament aggregation in neuronal perikarya and axons, (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 50 条
  • [21] Treatment of psychosis in Parkinson's disease and dementia with Lewy Bodies: A review
    Kyle, Kevin
    Bronstein, Jeff M.
    PARKINSONISM & RELATED DISORDERS, 2020, 75 : 55 - 62
  • [22] Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies
    Tetsuaki Arai
    Ian R. A. Mackenzie
    Masato Hasegawa
    Takashi Nonoka
    Kazhuhiro Niizato
    Kuniaki Tsuchiya
    Shuji Iritani
    Mitsumoto Onaya
    Haruhiko Akiyama
    Acta Neuropathologica, 2009, 117 : 125 - 136
  • [23] The role of α-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies
    Hofer, A
    Berg, D
    Asmus, F
    Niwar, M
    Ransmayr, G
    Riemenschneider, M
    Bonelli, SB
    Steffelbauer, M
    Ceballos-Baumann, A
    Haussermann, P
    Behnke, S
    Krüger, R
    Prestel, J
    Sharma, M
    Zimprich, A
    Riess, O
    Gasser, T
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (09) : 1249 - 1254
  • [24] LRRK2 in Parkinson's disease and dementia with Lewy bodies
    Xiongwei Zhu
    Asim Babar
    Sandra L Siedlak
    Qiwei Yang
    Genta Ito
    Takeshi Iwatsubo
    Mark A Smith
    George Perry
    Shu G Chen
    Molecular Neurodegeneration, 1
  • [25] LRRK2 in Parkinson's disease and dementia with Lewy bodies
    Zhu, Xiongwei
    Babar, Asim
    Siedlak, Sandra L.
    Yang, Qiwei
    Ito, Genta
    Iwatsubo, Takeshi
    Smith, Mark A.
    Perry, George
    Chen, Shu G.
    MOLECULAR NEURODEGENERATION, 2006, 1 (1)
  • [26] Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies
    Arai, Tetsuaki
    Mackenzie, Ian R. A.
    Hasegawa, Masato
    Nonoka, Takashi
    Niizato, Kazhuhiro
    Tsuchiya, Kuniaki
    Iritani, Shuji
    Onaya, Mitsumoto
    Akiyama, Haruhiko
    ACTA NEUROPATHOLOGICA, 2009, 117 (02) : 125 - 136
  • [27] Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies
    Higashi, Shinji
    Iseki, Eizo
    Yamamoto, Ryoko
    Minegishi, Michiko
    Hino, Hiroaki
    Fujisawa, Koshiro
    Togo, Takashi
    Katsuse, Omi
    Uchikado, Hirotake
    Furukawa, Yoshiko
    Kosaka, Kenji
    Arai, Heii
    BRAIN RESEARCH, 2007, 1184 : 284 - 294
  • [28] Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
    Jellinger, Kurt A.
    PARKINSONISM & RELATED DISORDERS, 2022, 100 : 24 - 32
  • [29] The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
    Andersson, M.
    Zetterberg, H.
    Minthon, L.
    Blennow, K.
    Londos, E.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 26 (01) : 100 - 105
  • [30] Parkinson's Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles
    Aldridge, Georgina M.
    Birnschein, Allison
    Denburg, Natalie L.
    Narayanan, Nandakumar S.
    FRONTIERS IN NEUROLOGY, 2018, 9